|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.1 SEK | +1.50% |
|
+1.25% | -29.87% |
| Apr. 25 | Iconovo AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 11 | Iconovo AB and Affilogic to Present Positive Data from a Feasibility Study on Nanofitins in ICOone | CI |
Iconovo AB (publ) reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was SEK 28.11 million compared to SEK 47.47 million a year ago. Net loss was SEK 45.89 million compared to SEK 48.16 million a year ago.
Basic loss per share from continuing operations was SEK 4.39 compared to SEK 5.44 a year ago. Diluted loss per share from continuing operations was SEK 4.39 compared to SEK 5.44 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -29.87% | 8.67M | |
| +9.64% | 27.27B | |
| -29.83% | 3.12B | |
| -15.97% | 2.53B | |
| +18.11% | 2.47B | |
| +3.70% | 2B | |
| -9.47% | 1.91B | |
| -2.22% | 1.48B | |
| +2.78% | 1.3B | |
| +18.92% | 1.18B |
ICONOVO AB 
